An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
Background: ATM, the protein defective in the human genetic disorder, ataxia-telangiectasia (A-T) plays a central role in response to DNA double-strand breaks (DSBs) and in protecting the cell against oxidative stress. We showed that A-T cells are hypersensitive to metabolic stress which can be acco...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25d6e71a108248368e69a3aaa026e679 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:25d6e71a108248368e69a3aaa026e679 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:25d6e71a108248368e69a3aaa026e6792021-11-14T04:32:37ZAn anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)2212-877810.1016/j.molmet.2021.101354https://doaj.org/article/25d6e71a108248368e69a3aaa026e6792021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2212877821002015https://doaj.org/toc/2212-8778Background: ATM, the protein defective in the human genetic disorder, ataxia-telangiectasia (A-T) plays a central role in response to DNA double-strand breaks (DSBs) and in protecting the cell against oxidative stress. We showed that A-T cells are hypersensitive to metabolic stress which can be accounted for by a failure to exhibit efficient endoplasmic reticulum (ER)-mitochondrial signalling and Ca2+ transfer in response to nutrient deprivation resulting in mitochondrial dysfunction. The objective of the current study is to use an anaplerotic approach using the fatty acid, heptanoate (C7), a metabolic product of the triglyceride, triheptanoin to correct the defect in ER-mitochondrial signalling and enhance cell survival of A-T cells in response to metabolic stress. Methods: We treated control cells and A-T cells with the anaplerotic agent, heptanoate to determine their sensitivity to metabolic stress induced by inhibition of glycolysis with 2- deoxyglucose (2DG) using live-cell imaging to monitor cell survival for 72 h using the Incucyte system. We examined ER-mitochondrial signalling in A-T cells exposed to metabolic stress using a suite of techniques including immunofluorescence staining of Grp75, ER-mitochondrial Ca2+ channel, the VAPB-PTPIP51 ER-mitochondrial tether complexes as well as proximity ligation assays between Grp75-IP3R1 and VAPB1-PTPIP51 to establish a functional interaction between ER and mitochondria. Finally, we also performed metabolomic analysis using LC-MS/MS assay to determine altered levels of TCA intermediates A-T cells compared to healthy control cells. Results: We demonstrate that heptanoate corrects all aspects of the defective ER-mitochondrial signalling observed in A-T cells. Heptanoate enhances ER-mitochondrial contacts; increases the flow of calcium from the ER to the mitochondrion; restores normal mitochondrial function and mitophagy and increases the resistance of ATM-deficient cells and cells from A-T patients to metabolic stress-induced killing. The defect in mitochondrial function in ATM-deficient cells was accompanied by more reliance on aerobic glycolysis as shown by increased lactate dehydrogenase A (LDHA), accumulation of lactate, and reduced levels of both acetyl CoA and ATP which are all restored by heptanoate. Conclusions: We conclude that heptanoate corrects metabolic stress in A-T cells by restoring ER-mitochondria signalling and mitochondrial function and suggest that the parent compound, triheptanoin, has immense potential as a novel therapeutic agent for patients with A-T.A.J. YeoG.N. SubramanianK.L. ChongM. GateiR.G. PartonD. ComanM.F. LavinElsevierarticleAtaxia-telangiectasiaATMNutrient deprivationEndoplasmic reticulum–mitochondrial interactionMitochondrial dysfunctionHeptanoate (C7)Internal medicineRC31-1245ENMolecular Metabolism, Vol 54, Iss , Pp 101354- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ataxia-telangiectasia ATM Nutrient deprivation Endoplasmic reticulum–mitochondrial interaction Mitochondrial dysfunction Heptanoate (C7) Internal medicine RC31-1245 |
spellingShingle |
Ataxia-telangiectasia ATM Nutrient deprivation Endoplasmic reticulum–mitochondrial interaction Mitochondrial dysfunction Heptanoate (C7) Internal medicine RC31-1245 A.J. Yeo G.N. Subramanian K.L. Chong M. Gatei R.G. Parton D. Coman M.F. Lavin An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T) |
description |
Background: ATM, the protein defective in the human genetic disorder, ataxia-telangiectasia (A-T) plays a central role in response to DNA double-strand breaks (DSBs) and in protecting the cell against oxidative stress. We showed that A-T cells are hypersensitive to metabolic stress which can be accounted for by a failure to exhibit efficient endoplasmic reticulum (ER)-mitochondrial signalling and Ca2+ transfer in response to nutrient deprivation resulting in mitochondrial dysfunction. The objective of the current study is to use an anaplerotic approach using the fatty acid, heptanoate (C7), a metabolic product of the triglyceride, triheptanoin to correct the defect in ER-mitochondrial signalling and enhance cell survival of A-T cells in response to metabolic stress. Methods: We treated control cells and A-T cells with the anaplerotic agent, heptanoate to determine their sensitivity to metabolic stress induced by inhibition of glycolysis with 2- deoxyglucose (2DG) using live-cell imaging to monitor cell survival for 72 h using the Incucyte system. We examined ER-mitochondrial signalling in A-T cells exposed to metabolic stress using a suite of techniques including immunofluorescence staining of Grp75, ER-mitochondrial Ca2+ channel, the VAPB-PTPIP51 ER-mitochondrial tether complexes as well as proximity ligation assays between Grp75-IP3R1 and VAPB1-PTPIP51 to establish a functional interaction between ER and mitochondria. Finally, we also performed metabolomic analysis using LC-MS/MS assay to determine altered levels of TCA intermediates A-T cells compared to healthy control cells. Results: We demonstrate that heptanoate corrects all aspects of the defective ER-mitochondrial signalling observed in A-T cells. Heptanoate enhances ER-mitochondrial contacts; increases the flow of calcium from the ER to the mitochondrion; restores normal mitochondrial function and mitophagy and increases the resistance of ATM-deficient cells and cells from A-T patients to metabolic stress-induced killing. The defect in mitochondrial function in ATM-deficient cells was accompanied by more reliance on aerobic glycolysis as shown by increased lactate dehydrogenase A (LDHA), accumulation of lactate, and reduced levels of both acetyl CoA and ATP which are all restored by heptanoate. Conclusions: We conclude that heptanoate corrects metabolic stress in A-T cells by restoring ER-mitochondria signalling and mitochondrial function and suggest that the parent compound, triheptanoin, has immense potential as a novel therapeutic agent for patients with A-T. |
format |
article |
author |
A.J. Yeo G.N. Subramanian K.L. Chong M. Gatei R.G. Parton D. Coman M.F. Lavin |
author_facet |
A.J. Yeo G.N. Subramanian K.L. Chong M. Gatei R.G. Parton D. Coman M.F. Lavin |
author_sort |
A.J. Yeo |
title |
An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T) |
title_short |
An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T) |
title_full |
An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T) |
title_fullStr |
An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T) |
title_full_unstemmed |
An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T) |
title_sort |
anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (a-t) |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/25d6e71a108248368e69a3aaa026e679 |
work_keys_str_mv |
AT ajyeo ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT gnsubramanian ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT klchong ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT mgatei ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT rgparton ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT dcoman ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT mflavin ananapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT ajyeo anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT gnsubramanian anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT klchong anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT mgatei anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT rgparton anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT dcoman anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat AT mflavin anapleroticapproachtocorrectthemitochondrialdysfunctioninataxiatelangiectasiaat |
_version_ |
1718429945359761408 |